Sionna Therapeutics, Inc.Insider Ownership
|
|
Current Insider Ownership
| Coulter James G | 10% Owner | Common Stock | Jan 22, 2026 | 6,494,962 | 14.43 | 247,328,153 |
| Winkelried Jon | 10% Owner | Common Stock | Jan 22, 2026 | 6,494,962 | 14.43 | 247,328,153 |
| Tpg Gp A, Llc | 10% Owner | Common Stock | Jan 22, 2026 | 6,494,962 | 14.43 | 247,328,153 |
| Orbimed Advisors Llc | Director | Common Stock | Feb 3, 2026 | 3,530,702 | 7.85 | 134,449,132 |
| Thompson Peter A. | Director | Common StockNon-Qualified Stock Option (right to buy) | Feb 3, 2026Jun 12, 2025 | 3,530,70219,959 | 7.850.04 | 134,449,132760,039 |
| Orbimed Capital Gp Viii Llc | Director | Common Stock | Feb 3, 2026 | 3,530,702 | 7.85 | 134,449,132 |
| Atlas Venture Fund Xi, L.P. | 10% Owner | Common Stock | Feb 10, 2025 | 807,727 | 1.80 | 30,758,244 |
| Atlas Venture Associates Xi, Llc | 10% Owner | Common Stock | Feb 10, 2025 | 807,727 | 1.80 | 30,758,244 |
| Atlas Venture Associates Xi, L.P. | 10% Owner | Common Stock | Feb 10, 2025 | 807,727 | 1.80 | 30,758,244 |
| Atlas Venture Opportunity Fund Ii, L.P. | 10% Owner | Common Stock | Feb 10, 2025 | 807,727 | 1.80 | 30,758,244 |
| Atlas Venture Associates Opportunity Ii, Llc | 10% Owner | Common Stock | Feb 10, 2025 | 807,727 | 1.80 | 30,758,244 |
| Atlas Venture Associates Opportunity Ii, Lp | 10% Owner | Common Stock | Feb 10, 2025 | 807,727 | 1.80 | 30,758,244 |
| Booth Bruce | Director | Common StockNon-Qualified Stock Option (right to buy) | Oct 21, 2025Jun 12, 2025 | 686,56719,959 | 1.530.04 | 26,144,471760,039 |
| Cloonan Michael | President & CEO | Common StockNon-Qualified Stock Option (right to buy)Stock Option (Right to Buy) | Oct 21, 2025Jan 2, 2026Feb 6, 2025 | 547,343489,242450,252 | 1.221.091.00 | 20,842,82118,630,33517,145,596 |
| Ra Capital Healthcare Fund Lp | Director | Common Stock | Nov 21, 2025 | 159,033 | 0.35 | 6,055,977 |
| Ra Capital Management, L.P. | Director | Common Stock | Nov 21, 2025 | 159,033 | 0.35 | 6,055,977 |
| Kolchinsky Peter | Director | Common Stock | Nov 21, 2025 | 159,033 | 0.35 | 6,055,977 |
| Shah Rajeev M. | Director | Common Stock | Nov 21, 2025 | 159,033 | 0.35 | 6,055,977 |
| Ra Capital Nexus Fund, L.P. | Director | Common Stock | Nov 21, 2025 | 159,033 | 0.35 | 6,055,977 |
| Ra Capital Nexus Fund Iii, L.P. | Director | Common Stock | Nov 21, 2025 | 159,033 | 0.35 | 6,055,977 |
| Ridloff Elena | CFO & Head of Corp. Dev. | Common StockNon-Qualified Stock Option (right to buy)Stock Option (Right to Buy) | Sep 2, 2025Jan 2, 2026Feb 6, 2025 | 38,532165,440157,820 | 0.090.370.35 | 1,467,2996,299,9556,009,786 |
| Clancy Paul J | Director | Non-Qualified Stock Option (right to buy) | Jun 12, 2025 | 19,959 | 0.04 | 760,039 |
| Stelzer Laurie | Director | Non-Qualified Stock Option (right to buy) | Jun 12, 2025 | 19,959 | 0.04 | 760,039 |
| Resnick Joshua | Director | Non-Qualified Stock Option (right to buy) | Jun 12, 2025 | 19,959 | 0.04 | 760,039 |
| Viney Joanne L. | Director | Non-Qualified Stock Option (right to buy)Stock Option (Right to Buy) | Jun 12, 2025Feb 6, 2025 | 19,95939,919 | 0.040.09 | 760,0391,520,116 |
| Fleming Harold Edward | Director | Non-Qualified Stock Option (right to buy) | Jun 12, 2025 | 19,959 | 0.04 | 760,039 |
| Ruddy Marcella K. | Director | Non-Qualified Stock Option (right to buy)Stock Option (Right to Buy) | Jun 12, 2025Feb 6, 2025 | 19,95939,919 | 0.040.09 | 760,0391,520,116 |
| Mckee Charlotte | Chief Medical Officer | Non-Qualified Stock Option (right to buy)Stock Option (Right to Buy) | Jan 2, 2026Feb 6, 2025 | 155,700148,536 | 0.350.33 | 5,929,0565,656,251 |
| Fitzpatrick Jennifer | Chief Legal Officer | Non-Qualified Stock Option (right to buy) | Mar 5, 2026 | 154,075 | 0.34 | 5,867,176 |
| Beer Caroline Stark | Chief Business Officer | Non-Qualified Stock Option (right to buy) | Jan 2, 2026 | 394,340 | 0.88 | 15,016,467 |
Insider Trading Trends
Insider Transactions
Voluntary Buys vs Sells
Historical Insider Trading (3-Years)
10b5-1
| Fitzpatrick Jennifer | NQSO | Common Stock | No | Yes | Exercise/Conversion | DISPOSE M | 6.11 | -10,250 | 62,628 | 50,935 | Mar 5, 2026 |
| Fitzpatrick Jennifer | Common Stock | No | Yes | Exercise/Conversion | ACQUIRE M | 6.11 | +10,250 | 62,628 | 10,250 | Mar 5, 2026 | |
| Fitzpatrick Jennifer | Common Stock | No | Yes | Sell | DISPOSE S | 33.86 | -10,250 | 347,019 | 0 | Mar 5, 2026 | |
| Orbimed Capital Gp Viii Llc | Common Stock | Yes | No | Sell | DISPOSE S | 44.58 | -29,063 | 1,295,629 | 3,530,702 | Feb 3, 2026 | |
| Orbimed Advisors Llc | Common Stock | Yes | No | Sell | DISPOSE S | 44.58 | -29,063 | 1,295,629 | 3,530,702 | Feb 3, 2026 | |
| Thompson Peter A. | Common Stock | Yes | No | Sell | DISPOSE S | 44.58 | -29,063 | 1,295,629 | 3,530,702 | Feb 3, 2026 | |
| Orbimed Capital Gp Viii Llc | Common Stock | Yes | No | Sell | DISPOSE S | 44.57 | -1,890 | 84,237 | 3,559,765 | Feb 2, 2026 | |
| Thompson Peter A. | Common Stock | Yes | No | Sell | DISPOSE S | 44.57 | -1,890 | 84,237 | 3,559,765 | Feb 2, 2026 | |
| Orbimed Advisors Llc | Common Stock | Yes | No | Sell | DISPOSE S | 44.57 | -1,890 | 84,237 | 3,559,765 | Feb 2, 2026 | |
| Coulter James G | Common Stock | Yes | No | Sell | DISPOSE S | 40.00 | -250,000 | 10,000,000 | 6,494,962 | Jan 22, 2026 |
1 - 10 of 606